IBI379, a novel B cell maturation antigen/CD3 bispecific T-cell engager, displays high antitumor efficacy in preclinical models of multiple myeloma
-
Published:2022-06
Issue:
Volume:536
Page:215663
-
ISSN:0304-3835
-
Container-title:Cancer Letters
-
language:en
-
Short-container-title:Cancer Letters
Author:
Fei Keke,
Ni Haiqing,
Zhu Mengjia,
Kuang Zhihui,
Wu Min,
Wu Zhihai,
Wang Feifei,
Zhou Shuaixiang,
Jing Hua,
Wu Weiwei,
Wu Dongdong,
Bai DongmeiORCID,
Chen Bingliang
Subject
Cancer Research,Oncology
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献